Attached: 1 image 🏭 The EU excels in innovative medicines but faces challenges: over 50% of medicine shortages are due to manufacturing issues and we also need to be vigilant about keeping generic drug production in Europe. Our Critical Medicine Act aims to: 💊 ensure that essential medicines are always available to EU patients, filling gaps where the market falls short 🇪🇺 boost local production 🧪 improve security of supply of key ingredients = more stability for the EU's pharmaceutical industry.